OSL:ZLNA - Euronext Oslo - NO0013524942 - Common Stock - Currency: NOK
OSL:ZLNA (4/25/2025, 7:00:00 PM)
16.5
+0.8 (+5.1%)
The current stock price of ZLNA.OL is 16.5 NOK. In the past month the price increased by 734.18%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
4AB.DE | ABBVIE INC | 18.11 | 285.16B | ||
AMG.DE | AMGEN INC | 14.09 | 131.97B | ||
GIS.DE | GILEAD SCIENCES INC | 22.32 | 112.70B | ||
VX1.DE | VERTEX PHARMACEUTICALS INC | 1723.6 | 110.78B | ||
ARGX.BR | ARGENX SE | 352.5 | 32.72B | ||
22UA.DE | BIONTECH SE-ADR | N/A | 24.54B | ||
IDP.DE | BIOGEN INC | 7.17 | 15.20B | ||
0QF.DE | MODERNA INC | N/A | 9.45B | ||
1MRNA.MI | MODERNA INC | N/A | 9.08B | ||
BIO.DE | BIOTEST AG | 24.8 | 1.68B | ||
GLPG.AS | GALAPAGOS NV | N/A | 1.54B | ||
BIO3.DE | BIOTEST AG-VORZUGSAKTIEN | 17.54 | 1.19B |
Zelluna ASA is a NO-based company operating in Biotechnology industry. The company is headquartered in Oslo, Oslo and currently employs 12 full-time employees. The company went IPO on 2019-06-03. Zelluna ASA, formerly Ultimovacs ASA is a Norway-based pharmaceutical company developing immunotherapies against cancer. The firm develops cell therapies for the treatment of cancer patients. Zelluna ASA deals with eliminate solid cancers by unleashing thel elements of the immune system through pioneering the development of T cell receptor (TCR) guided natural killer (NK) cell therapies. The firm provides benefit to patients, their families and all those around them, by developing therapies that bring together TCR guidance with the effector functions of allogeneic NK cells (TCR-NK) deploying a mechanism of action that has the potential to be both safe and potent. Zelluna ASA operates worldwide.
ZELLUNA ASA
Ullernchausseen 64
Oslo OSLO NO
Employees: 12
Company Website: https://www.zelluna.com/
Investor Relations: http://ultimovacs.com/investors
Phone: 4741380080
The current stock price of ZLNA.OL is 16.5 NOK. The price increased by 5.1% in the last trading session.
The exchange symbol of ZELLUNA ASA is ZLNA and it is listed on the Euronext Oslo exchange.
ZLNA.OL stock is listed on the Euronext Oslo exchange.
9 analysts have analysed ZLNA.OL and the average price target is 58.65 NOK. This implies a price increase of 255.45% is expected in the next year compared to the current price of 16.5. Check the ZELLUNA ASA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ZELLUNA ASA (ZLNA.OL) has a market capitalization of 333.80M NOK. This makes ZLNA.OL a Small Cap stock.
ZELLUNA ASA (ZLNA.OL) currently has 12 employees.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ZLNA.OL does not pay a dividend.
ZELLUNA ASA (ZLNA.OL) will report earnings on 2025-05-08.
ZELLUNA ASA (ZLNA.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.81).
ChartMill assigns a technical rating of 4 / 10 to ZLNA.OL.
ChartMill assigns a fundamental rating of 2 / 10 to ZLNA.OL. ZLNA.OL scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months ZLNA.OL reported a non-GAAP Earnings per Share(EPS) of -5.81. The EPS decreased by -5.77% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -173.53% | ||
ROE | -243.21% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 42% to ZLNA.OL. The Buy consensus is the average rating of analysts ratings from 9 analysts.